Avago Technologies Recommended on Weakness and 3 Stock Analyses to Follow

Celgene Corporation (NASDAQ:CELG): Current price $85.74

Jefferies raised their estimates and price target for Celgene Corporation noting the company’s new 2017 guidance, which the firm stated reflects stronger than expected operating margin leverage. Jefferies keeps a Buy rating on Celgene, which was upgraded at both RBC Capital and Piper Jaffray.

celg

Save time and make money with our LOWEST ADVERTISED PRICE EVER to help you achieve your financial goals in 2013. This is a LIMITED TIME OFFER, so get your Stock Picker Newsletter now!

Avago Technologies Limited (NASDAQ:AVGO): Current price $32.40

After meeting with the company at CES, Citi believes fears are overblown and that Avago Technologies Limited is well positioned to meet their January quarter wireless guidance. Citigroup recommends using the recent weakness in shares of Avago to add to positions in the name. The firm keeps a Buy rating on the stock with a $45 price target.

avgo

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

Moody’s Corp. (NYSE:MCO):  Current price $52.55

Benchmark Co. raised their estimates and price target for Moody’s Corp. and cited strong bond issuance and maintains a Buy rating on the stock.

mcgo

Save time and make money with our LOWEST ADVERTISED PRICE EVER to help you achieve your financial goals in 2013. This is a LIMITED TIME OFFER, so get your Stock Picker Newsletter now!

Syneron Medical Ltd. (NASDAQ:ELOS): Current price $8.90

After meeting with Syneron Medical Ltd.’s management, Cantor reported that the company expects their Syneron Beauty segment to break even this quarter. The firm believes that the company is poised to report “meaningful profitability” this year, and they reiterate a $16 price target and Buy rating on the stock.

Capture

Don’t Miss: Why is Chesapeake Cutting Back?